P59.05 Multi-Omic Analysis Between Tumor Tissues from Early and Late Stage Non-Small Cell Lung Cancer Patients

Patients with early or late stage non-small cell lung cancer (NSCLC) have significantly different prognosis. The epigenetic differences and gene expression profiles of different stages of NSCLC have not been fully explored. Multi-omic analysis between early and late stage NSCLC will greatly contribute to the understanding of progression mechanism and biomarker discovery.